Eli Lilly and Company (NYSE:LLY) Receives Consensus Recommendation of “Moderate Buy” from Brokerages
Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the twenty-one brokerages that are presently covering the stock, ...
pharmaphorum2d
Sanofi turns the tables on Lilly with biosimilar fast-acting insulin
Humalog, faces cut-price competition after the US regulator approved a biosimilar from Sanofi. Sanofi’s Admelog (insulin lispro) is approved in type 1 and type 2 diabetes as a follow-on drug to ...
Strategic Financial Concepts LLC Increases Position in Eli Lilly and Company (NYSE:LLY)
Strategic Financial Concepts LLC lifted its position in shares of Eli Lilly and Company (NYSE:LLY – Free Report) by 67.7% during the fourth quarter, according to the company in its most recent filing ...
pharmaphorum3d
Why the drug pricing debate is focused on insulin
According to research, one vial of Humalog (insulin lispro) cost $21 in 1999, but this increased to $332 in 2019, representing a price increase of 1480%. For its part, PhRMA, a trade group ...
Medscape2d
Room-temperature Storage of Medications Labeled for Refrigeration
28 days Prescribing information Insulin lispro (rDNA origin) vial Humalog vial (Lilly) 28 days Prescribing information NPH, human insulin isophane suspension (rDNA origin) Novolin N vial (Novo ...
Medscape3d
FDA Okays New Rapid-Acting Biosimilar Insulin for Diabetes
The US Food and Drug Administration (FDA) has approved Sanofi’s Merilog (insulin-aspart-szjj), a biosimilar to Novolog ...
Yahoo Finance3d
Eli Lilly and Company (LLY)
After hours: 7:59:56 pm GMT-5 ...